Clinical Trial Update: A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial

View source ↗

Summary

This clinical trial update reports on the safety-focused follow-up study ALLO-ASC-DFU-302 for diabetic foot ulcers, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• ALLO-ASC-DFU

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Diabetic Foot Ulcer | Status: RECRUITING